Use of Fentanyl Patch and Intravenous Morphine for Treatment of Leg Bone Fracture: Treatment Profile, and Clinical Effectiveness

Abolfazl Jokar; Koorosh Ahmadi; Leila Hajimaghsoodi; Saman Ketabi

doi:10.3889/oamjms.2018.413

Authors

Abolfazl Jokar Department of Emergency Medicine, Arak University of Medical Sciences, Arak
Koorosh Ahmadi Department of Emergency Medicine, Alborz University of Medical Sciences, Karaj
Leila Hajimaghsoodi Department of Surgery, Alborz University of Medical Sciences, Karaj
Saman Ketabi Department of Emergency Medicine, Arak University of Medical Sciences, Arak

DOI:

https://doi.org/10.3889/oamjms.2018.413

Keywords:

Transdermal fentanyl patches, Morphine, Pain

Abstract

BACKGROUND: Severe pain is one of the major problems in patients with leg bone fracture. Various methods have been proposed to relieve pain. Opioids are one of the most important available medications to control these types of pain. Among the opioids available, fentanyl can be applied for its unique properties as transdermal patches.

AIM: Therefore, the current study aimed to investigate the effect of intravenous morphine and fentanyl skin patch in patients with a lower leg fracture.

METHODS: We entered 60 patients in this randomised, one-blind randomised clinical trial among patients referring to the emergency department of Vali-e-Asr Hospital in Arak with a fracture of the leg. Demographic and clinical data were recorded for patients. The case group (n = 30) received the fentanyl patch in the same area. Patients in the control group (30) received 0.1mcg/kg of morphine intravenously. In both groups, the severity of pain was measured every 20 minutes within two hours after onset of treatment based on VAS criteria and subsequently recorded in the checklist. Data were analysed by SPSS v.22 software package.

RESULTS: The results of the present study demonstrated that the mean visual analogue scale (VAS) pain score at minutes 20, 40, 60 and 80 were statistically lower in intervention group when compared with the control group (p = 0.000).

CONCLUSION: Our results indicated a considerable risk-benefit profile for the treatment of pain in patients suffering from dysphagia, nausea and vomiting, or resistance to other opioids. The use of fentanyl patch is also suitable for patients who are not able to take their medication at their scheduled time.